The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved garadacimab (brand name Andembry) for patients aged 12 years and older with hereditary angioedema (HAE) to ...
The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...
H.C. Wainwright maintained a Buy rating on Astria Therapeutics stock, with a price target of $16.00. The firm's decision follows Astria's announcement of the initiation of a Phase 1a study for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback